Efficacy and Safety of Long-term Treatment with Lurasidone in Older Adults with Bipolar Depression: Results of a 6 Month Open-label Study

被引：1
|
作者：
Forester, Brent [1 ,2 ]
Sajatovic, Martha [3 ]
Tsai, Joyce [4 ,5 ]
Kroger, Hans [4 ,5 ]
Pikalov, Andrei [4 ,5 ]
Cucchiaro, Josephine [4 ,5 ]
Loebel, Antony [4 ,5 ]
机构：
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] McLean Hosp, Belmont, MA 02178 USA
[3] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[4] Sunov Pharmaceut Inc, Marlborough, MA USA
[5] Sunov Pharmaceut Inc, Ft Lee, NJ USA
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2015年 / 23卷 / 03期
关键词：
D O I：
10.1016/j.jagp.2014.12.178
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
NR 25
引用
收藏
页码：S170 / S171
页数：3
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: INTERIM ANALYSIS OF A TWO-YEAR OPEN-LABEL EXTENSION STUDY
    Goldman, Robert S.
    DelBello, Melissa P.
    Tocco, Michael
    Pikalov, Andrei A.
    Deng, Ling
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S137 - S137
  • [42] Lurasidone in bipolar I depression: a 24 week, open-label extension study
    Ketter, T. A.
    Sarma, K.
    Silva, R.
    Kroger, H.
    Cucchiaro, J.
    Loebel, A.
    Grossman, F.
    Pikalov, A.
    BIPOLAR DISORDERS, 2014, 16 : 131 - 131
  • [43] Lurasidone in Bipolar I Depression: A 24 Week, Open-label Extension Study
    Ketter, Terence
    Sarma, Kaushik
    Silva, Robert
    Xu, Jane
    Cucchiaro, Josephine
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S534 - S535
  • [44] Lurasidone in bipolar I depression: a 24 week, open-label extension study
    Ketter, T.
    Pikalov, A.
    Sarma, K.
    Silva, R.
    Kroger, H.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S443 - S444
  • [45] Effect of brexpiprazole on long-term remission in adults with schizophrenia: results of an open-label, long-term study
    Baker, R.
    Jin, N.
    Weiller, E.
    Weiss, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S952 - S952
  • [46] A Long-Term Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults With Schizophrenia
    Forbes, Robert
    Hobart, Mary
    Ouyang, John
    Pfister, Stephanie
    Hakala, Mika
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S409 - S410
  • [47] A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia
    Forbes, Andy
    Hobart, Mary
    Ouyang, John
    Shi, Lily
    Pfister, Stephanie
    Hakala, Mika
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (05): : 433 - 441
  • [48] Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan
    Inoue, Yushi
    Ohtsuka, Yoko
    EPILEPSY RESEARCH, 2015, 113 : 90 - 97
  • [49] Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia
    Chambers, Mark S.
    Jones, Christopher Uwe
    Biel, Merrill A.
    Weber, Randal S.
    Hodge, Kenneth M.
    Chen, Y.
    Holland, John M.
    Ship, Jonathan A.
    Vitti, Robert
    Armstrong, Ingrid
    Garden, Adam S.
    Haddad, Robert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (05): : 1369 - 1376
  • [50] Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study
    Filts, Yuriy
    Litman, Robert E.
    Martinez, Javier
    Anta, Lourdes
    Naber, Dieter
    Correll, Christoph U.
    SCHIZOPHRENIA RESEARCH, 2022, 239 : 83 - 91
12345